Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

QUANTUM GENOMICS Corp. - Product Pipeline Review - 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 23 | Code: MRS - 18619


Global Markets Directs, QUANTUM GENOMICS Corp. Product Pipeline Review 2014, provides an overview of the QUANTUM GENOMICS Corp.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of QUANTUM GENOMICS Corp.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides brief overview of QUANTUM GENOMICS Corp. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of QUANTUM GENOMICS Corp.s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the QUANTUM GENOMICS Corp.s pipeline products

Reasons to buy

Evaluate QUANTUM GENOMICS Corp.s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of QUANTUM GENOMICS Corp. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the QUANTUM GENOMICS Corp.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of QUANTUM GENOMICS Corp. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of QUANTUM GENOMICS Corp.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of QUANTUM GENOMICS Corp. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table Of Content 

Table of Contents 2
List of Tables 3
List of Figures 3
QUANTUM GENOMICS Corp. Snapshot 4
QUANTUM GENOMICS Corp. Overview 4
Key Information 4
Key Facts 4
QUANTUM GENOMICS Corp.- Research and Development Overview 5
Key Therapeutic Areas 5
QUANTUM GENOMICS Corp.- Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products- Monotherapy 8
QUANTUM GENOMICS Corp.- Pipeline Products Glance 9
QUANTUM GENOMICS Corp.- Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
QUANTUM GENOMICS Corp.- Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Discovery Products/Combination Treatment Modalities 11
QUANTUM GENOMICS Corp.- Drug Profiles 12
QGC-001 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
QGC-011 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
QGC-101 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
QGC-006 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
QUANTUM GENOMICS Corp.- Pipeline Products by Route of Administration 17
QUANTUM GENOMICS Corp.- Pipeline Products by Molecule Type 18
QUANTUM GENOMICS Corp.- Recent Pipeline Updates 19
QUANTUM GENOMICS Corp.- Dormant Projects 20
QUANTUM GENOMICS Corp.- Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21

Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 23
Disclaimer 23

List of Tables

QUANTUM GENOMICS Corp., Key Information 4
QUANTUM GENOMICS Corp., Key Facts 4
QUANTUM GENOMICS Corp.- Pipeline by Indication, 2014 6
QUANTUM GENOMICS Corp.- Pipeline by Stage of Development, 2014 7
QUANTUM GENOMICS Corp.- Monotherapy Products in Pipeline, 2014 8
QUANTUM GENOMICS Corp.- Phase II, 2014 9
QUANTUM GENOMICS Corp.- Preclinical, 2014 10
QUANTUM GENOMICS Corp.- Discovery, 2014 11
QUANTUM GENOMICS Corp.- Pipeline by Route of Administration, 2014 17
QUANTUM GENOMICS Corp.- Pipeline by Molecule Type, 2014 18
QUANTUM GENOMICS Corp.- Recent Pipeline Updates, 2014 19
QUANTUM GENOMICS Corp.- Dormant Developmental Projects,2014 20
QUANTUM GENOMICS Corp., Subsidiaries 21

List of Figures

QUANTUM GENOMICS Corp. - Pipeline by Top 10 Indication, 2014 6
QUANTUM GENOMICS Corp. - Pipeline by Stage of Development, 2014 7
QUANTUM GENOMICS Corp. - Monotherapy Products in Pipeline, 2014 8

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing